Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents
更正：奥比他韦/帕立普韦/利托那韦联合达沙布韦（含或不含利巴韦林）治疗同时服用抑酸剂的丙型肝炎病毒感染患者的安全性和有效性
期刊:American Journal of Gastroenterology
影响因子:7.6
doi:10.1038/ajg.2016.202
Shiffman, Mitchell L; Rustgi, Vinod; Bennett, Michael; Forns, Xavier; Asselah, Tarik; Vila, Ramon Planas; Liu, Li; Pedrosa, Marcos; Moller, Jonathan; Reau, Nancy
